Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Diabetes. Dec 15, 2013; 4(6): 234-237
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.234
Published online Dec 15, 2013. doi: 10.4239/wjd.v4.i6.234
Betatrophin: A liver-derived hormone for the pancreatic β-cell proliferation
Rajendra Raghow, Department of Veterans Affairs Medical Center, Memphis, TN 38104, United States
Rajendra Raghow, Department of Pharmacology, University of Tennessee Health Science Center, Memphis, TN 38163, United States
Author contributions: Raghow R solely contributed to this paper.
Correspondence to: Rajendra Raghow, PhD, Professor, Department of Veterans Affairs Medical Center, 1030 Jefferson Avenue, Memphis, TN 38104, United States. rraghow@uthsc.edu
Telephone: +1-901-5238990 Fax: +1-901-5237274
Received: August 2, 2013
Revised: September 2, 2013
Accepted: October 16, 2013
Published online: December 15, 2013
Processing time: 140 Days and 5.6 Hours
Revised: September 2, 2013
Accepted: October 16, 2013
Published online: December 15, 2013
Processing time: 140 Days and 5.6 Hours
Core Tip
Core tip: Yi et al have characterized a secreted protein named betatrophin that potently regulates β-cell proliferation. Evidently, betatrophin is identical to re-feeding-induced fat and liver protein, lipasin and atypical angiopoeitin-like 8, all of which were characterized as regulators of lipid homeostasis, by three independent groups of investigators. Yi et al were the first to demonstrate that hepatic expression of betatrophin in mice caused a dramatic surge in proliferation of the pancreatic β-cells with a concomitant improvement of their glucose tolerance. The discovery of a circulating hormone that specifically targets β-cell proliferation is a promising development towards a better clinical management of diabetes.